Register|Generate Password|Dos and Don'ts of Demat Account
For Login related queries e-mail: emkayassist@emkayglobal.com
"Attention Investors
1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. 6.Investor Charter 7.Disclosure of Complaints 8.COMPLAINTS / SCORES 9. Verify Nomination in Account, click on link (:: Central Depository Services (India) Limited :: )
.......... Issued in the interest of Investors"
Regenerate OTP
Please contact to emkayassist@emkayglobal.com
Please select Mobile No and Email Id for OTP
Customer Guest
Login | Register
Login | Register|Forgot password?
Disclosure under regulation 7(2) of SEBI (PIT) Regulations 2015.more...
Transcript of Earning Conference Call of Q4FY26.more...
Audio Recording of Q4FY26 Earnings Conference Callmore...
Investor Presentation for the Quarter and Year ended on March 31 2026.more...
Appointment of Cost Auditor and Internal Auditor of the company.more...
Board of Directors at its meeting held today May 18 2026 recommended a Final Dividend of Rs. 1/- Per Equity Sharemore...
Audited Financial Results for the Quarter and Year ended on March 31 2026.more...
The company reported standalone net profit of Rs 1.38 crore for the quarter ended March 31 2026 as compared to Rs 2.28 crore in the same per...more...
Outcome of Board meeting dated May 18 2026.more...
Intimation of Q4FY26 and FY26 Earnings Conference Call.more...
Bharat Parenterals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/05/2026 inter alia to consider an...more...
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1 Name of Company Bharat P...more...
Outcome of the U.S. FDA Inspection at Innoxel Lifesciences Private Limited subsidiary Company of Bharat Parenterals Limitedmore...
As of March 2026 67.17% is owned by Indian Promoters and 32.83% by Public. Top five Promoters holding highest number of shares of Bharat Par...more...
Clarification w.r.t query raised by BSE for clarification on the Price Movement of our security.more...
The Exchange has sought clarification from Bharat Parenterals Ltd on April 9 2026 with reference to significant movement in price in order t...more...
Compliance Certificate under regulation 74(5) of the SEBI (DP) Regulations 2018 for the quarter ended on March 31 2026.more...
Investor Presentation for the Quarter and Nine Months Ended on December 31 2025.more...
The company reported standalone net profit of Rs 1.92 crore for the quarter ended December 31 2025 as compared to Rs 6.50 crore in the same period la...more...
Unaudited Financial Results for the Quarter and Nine Months Ended on December 31 2025.more...
BOARD MEETINGS Company Name : Majestic Research Date : 30-06-2026